The high infectiousness and contagiousness of the SARS-CoV-2, as well as the alarmingly severe course of COVID-19, inspired research teams from around the world to begin an urgent search for effective methods to neutralize the new pathogen. The mRNA vaccine Comirnaty was the first conditionally licensed vaccine against SARS-CoV-2. Its key ingredient is a fragment of matrix RNA obtained by